首頁 › 間質性肺病 › 賓夕法尼亞州 › Philadelphia
Philadelphia, PA 的 間質性肺病 臨床試驗
16 項針對 間質性肺病 的研究正在 Philadelphia（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
招募中3 期
- University of Pennsylvania, Philadelphia
- Temple University, Philadelphia
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
招募中3 期
- University of Pennsylvania, Philadelphia
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
招募中2 期
- Thomas Jefferson University, Philadelphia
- Temple Lung Center, Temple University, Philadelphia
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
招募中3 期
- USA013, Philadelphia
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
招募中3 期
- GSK Investigational Site, Philadelphia
- GSK Investigational Site, Philadelphia
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
招募中3 期
- GSK Investigational Site, Philadelphia
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
招募中2/3 期
- GSK Investigational Site, Philadelphia
- GSK Investigational Site, Philadelphia
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
招募中
- Thomas Jefferson University, Philadelphia
- Temple University of The Commonwealth System of Higher Education, Philadelphia
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
招募中觀察性研究
- University of Pennsylvania, Philadelphia
- Thomas Jefferson University - Sidney Kimmel Medical College, Philadelphia
- Temple Lung Center, Philadelphia
- 還有 1 項
Platform Clinical Study for Conquering Scleroderma
招募中2 期
- University of Pennsylvania, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
招募中觀察性研究
- Temple University, Philadelphia
- Thomas Jefferson University, Philadelphia
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
招募中2 期
- Temple University, Philadelphia
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
招募中3 期
- Hospital of the University of Pennsylvania, Philadelphia
- Jefferson Honickman Center, Philadelphia
- Temple University Hospital, Philadelphia
TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
招募中觀察性研究
- Children's Hospital of Philadelphia, Philadelphia
Feasibility of Semaglutide in Advanced Lung Disease
招募中1/2 期
- University of Pennsylvania Perelman School of Medicine, Philadelphia
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
招募中2 期
- Temple University Hospital-Temple Lung Center, Philadelphia
其他城市的 間質性肺病 試驗
- New York City, NY18 項研究
- Los Angeles, CA14 項研究
- Charleston, SC13 項研究
- Kansas City, KS13 項研究
- Durham, NC13 項研究
- Chicago, IL12 項研究
- Houston, TX12 項研究
- Aurora, CO11 項研究
- Ann Arbor, MI11 項研究
- Dallas, TX9 項研究
- Salt Lake City, UT9 項研究
- Boston, MA9 項研究
Philadelphia 的其他研究
- 癌症（所有類型）59 項研究
- 乳癌56 項研究
- 非小細胞肺癌51 項研究
- 轉移性癌症46 項研究
- 前列腺癌44 項研究
- 大腸直腸癌44 項研究
- 卵巢癌44 項研究
- 肺癌36 項研究
- 急性髓系白血病34 項研究
- 心臟衰竭31 項研究
- 子宮內膜癌28 項研究
- 憂鬱症26 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。